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Abstract 
Multivariate methods are required to assess the interrelationships among 
multiple, concurrent symptoms. We examined the conceptual and contextual 
appropriateness of commonly-used multivariate methods for cancer symptom cluster 
identification. From 178 publications identified from an online database search of 
Medline, CINAHL, and PsycINFO, limited to articles published in English, 10 years 
prior to March 2007, 13 cross-sectional studies met the inclusion criteria. Conceptually, 
common factor analysis (FA) and hierarchical cluster analysis (HCA) are appropriate for 
symptom cluster identification, not principal component analysis. As a basis for new 
directions in symptom management, FA methods are more appropriate than HCA. 
Principal axis factoring or maximum likelihood factoring, the scree plot, oblique 
rotation, and clinical interpretation are recommended approaches to symptom cluster 
identification. 
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Recognition that cancer patients usually experience multiple disease- and 
treatment-related symptoms has prompted the exploration of symptom clusters  {Dodd, 
2005 #334; Dodd, 2001 #149; Given, 2007 #810; National Institutes of Health State-of-
the-Science Panel, 2003 #221}. Symptom clusters have been defined as groupings of at 
least two related, co-occurring symptoms, that are stable (reproducible), and relatively 
independent of other groupings {Kim, 2005 #505}. The potential utility of identifying 
symptom clusters lies in prioritizing symptoms for assessment and developing new 
directions in symptom management {Lacasse, 2007 #626; Williams, 2007 #627; 
Miaskowski, 2004 #452}. For instance, judicious choice of an intervention to relieve 
one symptom in a cluster may also relieve related symptoms, if biochemical or other 
biological similarities exist across symptoms within a cluster. This would result in 
treatment efficiencies, reduced side-effects, and improved patient outcomes {Walsh, 
2006 #413; Esper, 2005 #98; Fleishman, 2004 #389}. A proposed foundation for 
improved symptom management, based on the analysis of symptom clusters, includes an 
understanding of which symptoms commonly experienced by patients consistently form 
groupings across the disease trajectory, and identifying the underlying causes of those 
symptom groupings. 
When several symptoms consistently co-occur, their interrelationships may be 
complex, and multivariate analyses are required to describe those relationships {Hair, 
2006 #549}. The relevance of conducting exploratory, hypothesis-generating, 
multivariate analyses in this early stage of cancer-related symptom cluster research has 
been for theory development, based on empirical data from several studies. With 
increased knowledge, investigators may conduct hypothesis-testing (confirmatory) 
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studies. Despite the diversity of statistical methods to model symptom clusters {Kim, 
2008 #835}, there is no agreement either on best-practice multivariate approaches to 
identify symptom clusters {Fan, 2007 #695; Barsevick, 2006 #380}, or on which 
statistical methods will best identify groupings that are both theoretically and clinically 
useful {Kim, 2005 #505; Barsevick, 2006 #380; Barsevick, 2007 #624; Miaskowski, 
2007 #721}. 
The aims of this review were (a) to synthesize the considerations necessary to 
provide a transparent basis for selecting analytical methods for symptom cluster 
identification, and (b) to examine the multivariate methods that have been commonly 
used to identify symptom clusters, specifically in the context of cancer, with reference to 
(a) the conceptual and contextual appropriateness of the methods, and (b) the extent to 
which interpretation and application of the results obtained by these methods are 
clinically relevant. Several works on multivariate methods provide guidelines for 
grouping variables {Hair, 2006 #549; Child, 2006 #755; Byrne, 2001 #751; Pett, 2003 
#534}, but this review specifically addresses why, and whether, the methods that have 
been used in studies of cancer patients are appropriate for this purpose. As such, this 
review provides some basis for proposing consistent approaches to identifying symptom 
clusters in future cancer studies.  
Historically, across disciplines, symptom clusters have been identified either by 
clinical observations or by the statistical analysis of empirical data {Kim, 2005 #505}. 
Clinical approaches would tend to be confirmatory, as no a priori assumptions about the 
symptom groupings are made in exploratory analyses. Hence, the choice of approach is 
dictated by the research goal and existing knowledge. For example, the regular 
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occurrence of symptoms as a grouping may be assessed clinically, but a statistical 
analysis is required to determine unknown groupings that are likely to occur, based on 
the symptom experience of individuals. At the same time, statistically-identified 
symptom groupings must also be clinically meaningful. A symptom grouping is 
clinically relevant if the identified symptoms are important to the patient’s experience, 
the grouping occurs commonly (indicating stability), and it has some practical 
consequence for both symptom management (e.g., clinician assessment or intervention) 
and patient outcomes (e.g., improved functionality). 
Selection of an Analytical Method 
Selection of an appropriate analysis for identification of symptom clusters 
depends on the conceptualization of a symptom cluster in this clinical context, a 
conceptual understanding of the method, and an alignment of the analytical method to 
the research context. The research context incorporates the nature of the research 
question, the intended application of results, timing of the data collection (cross-
sectional/longitudinal), and the nature of the sample (e.g., different patient subgroups). 
For example, if the purpose is to identify unknown groupings from a range of 
symptoms, either hierarchical cluster analysis (HCA) or exploratory factor analysis 
(EFA) is appropriate, but to validate hypothesized groupings, confirmatory factor 
analysis (CFA) is more appropriate. Furthermore, if the symptom experience varies for 
patients by diagnosis, stage of disease, treatment, or demographic characteristics, a 
theoretically-complete analysis incorporates subgroup analyses, to investigate symptom 
groupings for each scenario.  
Conceptual and Contextual Basis for Method Selection 
   
 
 
5  
EFA is the most commonly-applied method of cancer symptom cluster 
identification {Kim, 2005 #505; Barsevick, 2006 #380}, but HCA may also group 
symptoms if the goal is to analyze the structure in the data {Hair, 2006 #549}. These 
methods capture the attributes of a symptom cluster (i.e., related and concurrent 
symptoms), but they differ, both conceptually and mathematically, and are relevant in 
different contexts. For instance, if symptoms are etiologically independent yet co-occur, 
either factor or cluster analysis is appropriate to identify groupings. However, if 
symptoms are related because they are likely to arise from some common cause, only 
factor analysis is appropriate, as the underlying concept in factor analysis is that the 
observed variables (e.g., dry mouth, drowsiness, appetite loss) are indicators of some 
unobserved factors (e.g., chemotherapy-related factor). In cluster analysis, similar 
symptoms are assigned to groups, based on the proximity (distance) of ratings or similar 
response patterns (correlations) across individuals, and underlying constructs are not a 
consideration. 
Principles of EFA 
When conducting EFA, researchers must decide, from several options, which 
variables and individuals to include in the study, the method of extraction, the method to 
determine the number of factors to retain, and the method of rotation.     
Common FA versus principal components analysis. Selection of a factor extraction 
method depends on the goal of the analysis. In standard statistical programs (e.g., SPSS, 
SAS), factoring procedures include common FA methods (e.g., principal axis factoring 
[PAF] and maximum likelihood [ML] factoring) and principal components analysis 
(PCA). The goal of common FA is to identify a coherent set of interrelated variables that 
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are indicators of a few underlying factors (e.g., symptoms may be indicators of disease 
or treatment). In the common factor model {Thurstone, 1947 #787}, each measured 
variable is a linear combination of one or more common factors and one unique factor 
that accounts for errors {Gorsuch, 1983 #620}. Only the common variance 
(communality) a variable shares with the other variables is assessed. In most common 
FA methods, communality estimates are based on the covariance (correlation) between 
variables. In contrast, PCA was developed as a data reduction technique to determine a 
few components to replace the original variables exactly, by accounting for the total 
variance in a variable. Each measured variable is a linear combination of the 
components, and there are no assumptions about an underlying structure or causality. 
Hence, in this context of grouping symptoms to investigate underlying common factors 
and symptom causation, common FA methods are more appropriate than PCA.  
Researchers have shown that similar groupings may result from common FA and 
PCA, provided the communalities are high (>.70), suggesting the variables have much 
in common, and the number of variables exceeds 30, as the communalities have 
proportionately less impact on the solution (Gorsuch, 1990). However, loadings 
(associations between variables and components/factors) in PCA may be larger, due to 
the inclusion of error variance {Snook, 1989 #824}. Consequently, variables that 
otherwise would have been excluded in common FA may be included in PCA, due to 
spurious relationships. Velicer and Jackson (1990) found differences between methods 
were of little practical importance, but were more likely to occur when factors were 
identified by a few, weakly associated variables. 
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Number of factors. The number of factors can be determined statistically in ML 
by testing an increasing number of factors to find the model that best reproduces the 
original correlations, assessed by goodness-of-fit indices. In PCA, a criterion to suggest 
the number of components to retain is the number of components with eigenvalues (the 
amount of variance in the variables accounted for by a component) greater than 1.0. In 
this instance, each component accounts for more than its share of the total variance 
among the variables. However, this method often leads to over-extraction {Velicer, 
1990 #782}. A preferred approach to indicate how many factors account for the majority 
of the common variance is the scree plot of eigenvalues against the number of factors. In 
standard software, this is the most appropriate approach for FA (apart from ML), and 
preferable when eigenvalues are calculated for the correlation matrix with 
communalities on the main diagonal {Fabrigar, 1999 #688}, although this option is not 
available in SPSS.  
Rotation. To improve interpretability, the axes are rotated to achieve simple 
structure, indicated when symptoms have strong associations with one factor and weak 
associations with all other factors {Thurstone, 1947 #787}. The relationship between 
symptoms and factors is estimated by both the pattern coefficients, indicating the unique 
contribution of each factor to a variable, and the structure coefficients, indicating the 
correlation between factors and variables, and accounting for any correlation between 
factors {Manly, 2005 #761}. Oblique rotation allows factors to be correlated and higher 
order analyses are implied for strongly correlated factors {Child, 2006 #755}. Higher-
order factors could lead to broader factors accounting for the primary factors {Gorsuch, 
1983 #620}. For example, a second-order factor solution would reveal whether all first-
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order factors could be attributed to a single cause (e.g., cancer) or could come from two 
causes (e.g., cancer and depression). In contrast, the groupings may be distinct, but 
related, and may not reflect a higher-order factor at all.  
Principles of Agglomerative Hierarchical Cluster Analysis 
The structure in symptom responses is identified by HCA, in stepwise 
procedures {Hair, 2006 #549}. There is no supposition of underlying relationships. 
Grouping is based on various quantitative measures of similarity, such that symptoms in 
the same cluster are more similar to each other than to symptoms in another cluster. For 
example, if the pattern of responses to two symptoms is similar for most individuals, the 
symptoms are grouped, whereas different response patterns suggest symptoms are rated 
more independently. Squared Euclidean distances and correlations are common 
similarity measures for interval data. For binary data, coefficients of association are 
calculated, based on whether paired variables are present, absent, or one is absent and 
one present. For example, the Jaccard coefficient excludes symptoms that are both 
absent {Everitt, 1980 #617}, and the phi coefficient is the binary equivalent of the 
Pearson correlation coefficient {Aldenderfer, 1984 #403}. Groups are linked 
successively to the nearest grouping until all groups are joined. This hierarchical 
structure is represented in a dendrogram, showing variables in each grouping, and the 
distance between groupings. The level at which the joins are interpreted as meaningful 
categorizations is arbitrarily chosen by the researcher to reflect the context. There are 
few assumptions, but symptoms should be representative of the symptom experience in 
the population (e.g., 10% of individuals in the sample and in the population experience 
breathlessness), so sample size is determined to reflect this representation. Symptoms 
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that are under-represented may not group with other symptoms, so may be incorrectly 
identified as outliers. Higher-order groupings may be identified from the hierarchical 
structure {Beckstead, 2002 #795}. 
Analytical Methods and Stability of Symptom Clusters 
Stability is necessary for identified symptom clusters to be clinically useful in 
the cancer treatment and follow-up trajectory, although cancer symptom clusters also 
may be dynamic constructs across the disease trajectory {Kirkova, 2007 #696}. 
Investigation of stability over time requires longitudinal studies. In exploratory analyses, 
the number and nature of the groupings are unknown, so analyses that demonstrate 
statistical stability are important to confirm that solutions are not simply due to chance. 
The stability of groupings is determined, ideally, by replicating the original study in a 
similar sample (i.e., cross-validation), or less-rigorously, over time in the same sample, 
under the implicit assumption that symptom clusters would not be dynamic in the given 
context. In FA, stability is indicated by similar patterns of coefficients, and in HCA, by 
similar structures in the dendrograms {Hair, 2006 #549}. Following FA, hypotheses of 
the relationships among symptoms and the common factors can be tested statistically 
(validated) in a similar but independent sample, using CFA {Haig, 2005 #831}. In HCA, 
there is no confirmatory cluster analysis to statistically test hypothesized groupings, so 
validation of clusters depends on repeating HCA for a similar sample. 
Study design issues for stability 
The approach to sampling both individuals and symptoms influences the 
accuracy and stability of groupings {Costello, 2005 #789; Fabrigar, 1999 #688}. 
Furthermore, researchers have shown that a stable solution depends on the collective 
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influence of sample size, communality levels, and an adequate number of items 
indicating each factor (saturation), rather than on the ratio of cases to variables, which is 
the guideline used typically to determine sample size {MacCallum, 1999 #793}. For 
example, for low communalities (<.50) and 3-4 indicators per factor, a sample size of 
300 or more may be required. A minimum of three indicators per factor is suggested for 
stability {Child, 2006 #755}, although a two-item cluster may be stable if the items are 
highly-correlated {Tabachnick, 2007 #559}. Thus, the number of items appears not to 
be the most sensitive of the criteria. In exploratory analyses, the number of items per 
factor is unknown a priori, and communalities are estimated, so as large a sample size as 
practicable is warranted to avoid instability, and preferably, the range of symptoms 
experienced by that cancer population is assessed.  
Guidelines for Analytical Decisions 
In exploratory factor and cluster analyses, there are no inferential statistics on 
which to base analytical choices, so decisions are based on guidelines and contextually-
appropriate interpretation by the researchers. From the social science literature, the 
following best-practice guidelines have been recommended for EFA {Costello, 2005 
#789}: (a) common FA methods of extraction, using ML for approximately normal data, 
or PAF for non-normal data; (b) the scree plot with analyses repeated for a varying 
number of factors, until groupings are contextually meaningful; (c) oblique rotation, as 
this includes the situation where factors are orthogonal, the latter being the default 
choice within many statistical packages; (d) pattern coefficients greater than ±.30, a 
commonsense minimum indicating that almost 10% of variance in the symptom is 
shared with the latent factor, after controlling for the correlation between factors; (e) no, 
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or few, symptoms with strong associations with several factors (cross-loading); (f) at 
least three items per factor; (g) a minimum sample size exceeding 100; and (h) reporting 
the pattern, structure, and factor correlation matrices.  
Best-practice guidelines are more limited for HCA, with no model and few 
assumptions. The average linkage method of determining mathematical distances 
(dissimilarities) between identified groups is recommended when classifying variables 
{Timm, 2002 #647}. Generally, researchers arbitrarily assign cut-points where large 
increases in distances occur between groupings and the groupings are interpretable 
clinically.   
Review of Cluster Analysis Studies 
Although a previous literature review of the variation in cancer symptom clusters 
exists {Fan, 2007 #695}, there was no discussion in that review of the statistical 
methods by which clusters were identified. In a recent study by Kim and Abraham 
(2008), several statistical approaches to model symptom clusters from a conceptual and 
methodological perspective were examined. In contrast, this current literature review 
considers alternative multivariate methods applied in cancer symptom cluster studies, 
why particular approaches were used by researchers, and which methods can be 
recommended, based on their conceptual and contextual appropriateness.  
 
Method 
Search Strategy  
For this review, an online database search of Medline, CINAHL, and PsycINFO 
was conducted searching from March 1997 to March 2007. Using EBSCOhost as the 
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database, the search terms were: cancer and symptom* and cluster*. Multivariate was 
not included as a search term, as it commonly refers to regression analyses (i.e., 
multivariable analyses of relationships between independent and dependent variables), 
and did not identify additional true multivariate (analysis of relationships between 
multiple dependent variable) studies. The search resulted in 178 articles.  
Inclusion/Exclusion Criteria 
A checklist of inclusion/exclusion criteria was used for consistency between two 
reviewers to reach agreement on the studies to be included. The inclusion criteria 
required that: (a) articles were published in English from March 1997 to March 2007, 
(b) the target population was adults diagnosed with primary cancer, (c) studies were 
cross-sectional, and (d) symptom clusters were identified using multivariate statistical 
methods. Studies were excluded if: (a) symptom clusters were determined a priori, not 
statistically; (b) patients, not symptoms, were grouped; (c) single symptoms, symptom 
correlates, or symptoms indicating a specific psychological condition (e.g., symptoms 
indicating Post-Traumatic Stress Disorder) were assessed; and (d) studies were literature 
reviews, expert opinion, conference abstracts, dissertations, or duplicate studies. 
Overall, 13 studies met the inclusion criteria. Two further studies were identified from a 
hand-search of the reference lists of these studies. Only two longitudinal studies were 
identified, so the authors have restricted this review to the 13 cross-sectional studies. For 
each study, the research purpose, study design, key analytical decisions, and the 
identified symptom groupings were summarized in separate tables, by type of analysis 
(FA, PCA, and HCA; see Tables 1-3). 
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The focus of this review was to understand why investigators made particular 
analytical decisions in relation to the conceptual and contextual appropriateness of these 
methods. Contextual appropriateness of analytical choices was considered with 
reference to the purpose of the study and the intended clinical application, which can 
vary from symptom assessment to intervention. In EFA, key analytical choices include 
the methods of: (a) extraction, (b) determining the number of factors, and (c) rotation. In 
HCA, key analytical choices are: (a) the similarity measure, (b) method of linkage, and 
(c) the method determining the number of clusters.  
 
Results 
Commonly Used Multivariate Methods 
Systematic searching of the literature published in the 10 years prior to 
March 2007 identified 6 studies using PAF and 1 ML study (see Table 1), 3 
studies using PCA (see Table 2), and 3 studies using HCA (see Table 3). Their 
application included symptom cluster identification and development of a 
symptom assessment instrument. Samples included patients with lung cancer (2 
studies), breast cancer (2 studies), brain tumors (1 study), and mixed diagnoses (8 
studies). Various instruments were used to assess from 13 to 32 symptoms, and 
their administration varied with respect to diagnosis, treatment phase, and disease 
stage. The presence of various cancer subgroups suggests the need for separate 
subgroup analyses, but these were not conducted, mainly due to limited sample 
sizes.  
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The number of groupings increased as the number of symptoms increased, 
independent of the analytic method, although the number of factors that can be 
extracted by FA methods is limited by the number of symptoms assessed. Using 
HCA, seven groupings were identified from 25 symptoms {Walsh, 2006 #413} 
and one grouping from 8 symptoms {Glaus, 2006 #431}. For PAF, two and three 
groupings were identified from 13 items on the M.D. Anderson Symptom 
Inventory (MDASI; see Table 1). Similarly, using PCA, six groupings were 
identified from 22 symptoms (Armstrong et al., 2006) and four groupings from 13 
symptoms (Sarna & Brecht, 1997). Cluster analysis typically identifies more 
groupings than FA methods, but this trend was not evidenced here.    
Conceptual and Contextual Nature of the Method Selection 
Across studies, analyses were selected to address the specific research 
purpose. When the purpose was simply to identify symptom groupings, HCA was 
implemented. However, when the purpose was to identify symptom groupings and 
consider underlying constructs, PAF, ML, and PCA were implemented. 
Conceptually, PCA does not address this second research purpose, and the 
groupings may have differed if determined by FA methods. 
The intended application in all studies was associated with symptom 
assessment/management, but in the HCA studies, this contextual aspect was not 
explicitly stated in the research purpose. For example, Walsh and Rybicki (2006) 
speculated on the possible causes associated with symptoms in each cluster (e.g., 
possibly due to a shared common pathophysiology), so using FA would have 
provided a strong conceptual basis for identification and interpretation of the 
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symptom clusters, and for further investigation of the underlying constructs. 
Furthermore, with a sample size over 900, the researchers had the opportunity to 
randomly split the sample, and conduct an EFA to identify symptom groupings on 
half the data, then test this hypothesized structure in a CFA on the second half. In 
other studies {Bender, 2005 #485; Glaus, 2006 #431}, HCA was used for an 
initial exploration of the data structure. In a set of studies designed to test the 
validity and reliability of the MDASI for English, Russian, Chinese, Japanese, and 
Filipino cancer patients, PAF was used to identify symptom groupings. Reliability 
testing is conceptually inherent in FA, but FA is only the first step to determine 
construct validity, by identifying the underlying constructs to be confirmed in 
similar studies. Chen and Tseng (2006) were interested in the conceptual 
meanings of symptom clusters, so PAF was appropriate.  
Analytical Decisions in EFA 
The justification for key analytical decisions was seldom described by 
researchers. The majority of studies used common FA methods. In one study, ML 
was used to determine that four common factors were appropriate, but only one 
factor of seven symptoms with coefficients above .40 was retained {Gift, 2004 
#450}. A trend for analytical choices implemented in successive MDASI studies 
using PAF, oblique rotation, and Harman’s rule to determine the number of 
groupings was set by Cleeland and colleagues (2000). Harman’s rule states that for 
a specified number of groupings, if the calculated standard deviation of the 
residuals is just less than the reciprocal of the square root of the sample size, that 
solution is acceptable {Harman, 1976 #633}. Some MDASI studies also used the 
   
 
 
16  
scree plot and eigenvalues > 1.0 to decide on the number of factors. Chen and 
Tseng (2006) used eigenvalues >1.0 to determine two factors (as in the original 
MDASI study), but on the basis of conceptual meanings, they forced a 3-factor 
solution, which was similar to the 3 groupings identified for Russian cancer 
patients {Ivanova, 2005 #616}. In contrast, the combined procedures of PCA, 
eigenvalues > 1.0, and varimax rotation were used by {Sarna, 1997 #528; 
Mystakidou, 2004 #473}, but Armstrong et al. (2006) used Harman’s rule to 
determine the number of groupings.  
In all studies, groupings were identified from an interpretation of the pattern 
coefficients and consideration of the clinical sense of the grouped symptoms. Only Chen 
and Tseng (2006) reported inter-factor correlations (.43 to .56), but higher order 
analyses were not considered. Pattern coefficient cut-off values of .30 and .40 (see 
Tables 1, 2) were not declared a priori, but researchers tended to arbitrarily select this 
value from observed patterns in the coefficients. In most studies, the number of 
groupings was determined by more than one criterion (see Tables 1, 2), but the 
suggested number of groupings often differed by criterion. Consequently, analyses 
tended to be repeated for differing numbers of factors until clinically-interpretable 
groupings were determined. For example, Wang et al. (2006) explored 4-factor 
groupings using eigenvalues > 1.0, and tried 3 factors, but the 2-factor solution 
suggested by Harman’s rule was considered more clinically-relevant, although two 
symptoms had loadings below .30.  
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Analytical Decisions in HCA 
For HCA, key decisions varied across studies (see Table 3). The choice of 
similarity measures was influenced by different symptom measurements. For example, 
for symptom severity ratings, squared Euclidean distances {Cleeland, 2000 #308; 
Mystakidou, 2004 #473; Okuyama, 2003 #474; Glaus, 2006 #431} and correlations 
{Walsh, 2006 #413; Glaus, 2006 #431} were appropriate. For symptom occurrence 
(binary responses), Jaccard’s coefficient {Glaus, 2006 #431}, and the phi correlation 
coefficient {Bender, 2005 #485} were calculated, but without justification for their 
selection. The number of groupings was decided from a combination of visual 
inspection of the dendrogram and clinical interpretation of groupings. Walsh and 
Rybicki identified seven clusters, using an arbitrary correlation cut-point of .68, 
determined from the data structure. 
Stability of Symptom Groupings 
The stability of groupings associated with the 13-item MDASI was investigated 
by cross-validation of studies of similar outpatient samples {Cleeland, 2000 #308; 
Mystakidou, 2004 #473; Wang, 2006 #543} and in a community sample of adults with 
no diagnosis of cancer {Wang, 2006 #543}. Similar patterns of coefficients were 
consistently identified across these samples. Differences were: numbness not loading on 
either of the two factors {Cleeland, 2000 #308} and pain and sleepiness cross-loading 
on two of the three factors {Mystakidou, 2004 #473}. The structure in the MDASI was 
identified as two groupings using PAF in four studies, and also by using HCA in three 
of these studies. However, three groupings were identified by Chen and Tseng (2006) 
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and Ivanova et al. (2005). Groupings identified by HCA (see Table 3) were not cross-
validated.  
In HCA studies, most investigators did not report how representative the 
symptoms were of the symptom experience in the population, but Walsh and 
Rybicki (2006) reported that symptoms were relevant, both clinically and 
therapeutically, to the cancer population in the USA. In some studies, symptoms 
were excluded, prior to grouping, if prevalence rates were below 15% {Walsh, 
2006 #413; Glaus, 2006 #431}, or if symptoms were considered redundant (i.e., 
symptoms were rated similarly by patients and were intuitively the same 
symptom; {Cleeland, 2000 #308; Armstrong, 2006 #610; Mystakidou, 2004 
#473}. Mathematically-identified redundant symptoms that were clinically distinct 
(e.g., nausea and vomiting) were retained, as clinicians felt these symptoms lead to 
different clinical decisions.  
Communalities, sample size, and factor saturation varied across studies. 
Sample size ranged from less than 100 {Sarna, 1997 #528} to more than 200 in 
seven studies. The largest study (N=922) was by Walsh and Rybicki (2006) using 
HCA, in which clinically-relevant symptom groupings were identified. In the FA 
studies (see Table 1), the minimum ratio of the number of patients to variables 
exceeded 5:1 in one study {Armstrong, 2006 #610; Gift, 2004 #450}, and 
exceeded 10:1 in the remaining studies. Only Gift et al. reported communalities, 
and these communalities were small (.20 to .30), indicating that for most of the 
variables there was minimal shared variance, which may explain why only one 
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symptom grouping was identified. The number of symptoms in groupings ranged 
from 2 to11 across studies.   
Clinical Relevance and Interpretation of Groupings 
Substantive interpretation of groupings was an important aspect in these 
exploratory studies when different numbers of groupings were explored. For example, 
Ivanova et al. (2005) adopted a 3-factor solution, which satisfied Harman’s criterion, 
rather than their difficult to interpret 4-factor solution based on eigenvalues, or the 2-
factor solution, which was clinically meaningful, but did not satisfy Harman’s criterion. 
The clinical relevance of groupings was considered in terms of face validity, but was 
questioned when symptoms known from clinical studies to be prevalent or severe 
{Cleeland, 2000 #233; Walsh, 2000 #344; Cooley, 2003 #257} were not always 
identified in the groupings. For example, dyspnea, cough, and pain frequently co-occur 
in lung cancer patients, but did not form part of the grouping identified by Gift et al. 
(2004).  Investigators attributed this to inconsistent response patterns and small 
communalities, possibly due to co-occurrence assessed over the past 2 weeks, rather 
than assessed clinically (e.g., in past 24 hours).  
Some groupings identified in studies, either from a limited range of symptoms or 
for a specific sample, may not be generalizable. For example, symptom clusters 
identified from symptoms specific to breast cancer patients {Glaus, 2006 #431} may not 
be relevant to all cancer patients. In Sarna and Brecht’s study (1997), symptom 
groupings associated with female lung cancer patients could not be generalized to all 
lung cancer patients, as important symptoms (e.g., hemoptysis and dyspnea) were not 
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assessed, and men with lung cancer may have a different symptom experience compared 
to women. 
Discussion 
This review has investigated alternative methods to identify cancer symptom 
clusters at a cross-sectional point in time. The conceptual appropriateness of these 
methods cannot be determined from the reviewed studies, but can be justified 
theoretically and mathematically, based on the concept of a symptom cluster and the 
principles of factor and cluster analysis, respectively. For cross-sectional data, when the 
number and nature of the groupings are unknown, HCA and FA are both conceptually-
appropriate methods to group symptoms, based on the assumption that the symptoms in 
a grouping are related and concurrent. 
Although not always stated explicitly, selection of an analytical method was 
either linked to the research purpose, or based on choices made in other studies. For 
example, Wang and colleagues (2004) stated that their analytical approach followed 
Cleeland et al. (2000), while other researchers did not state why a particular method was 
selected, possibly assuming this was obvious (e.g., assuming PAF is a standard approach 
to assess construct validity). In studies where the goal was simply to identify groupings, 
HCA was selected. However, when the underlying constructs or the potential causal 
links to symptoms in a grouping were of interest, PAF, ML, or PCA were used, although 
PCA was not designed to identify underlying constructs and may determine misleading 
results for symptom groupings.  
Few investigators stated explicitly the intended application of the research, but 
there was some discussion of the symptom interrelationships as a basis for improved 
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symptom assessment and management. However, analytical methods were not always 
linked to the intended application. In particular, studies based on the interpretation and 
application of symptom clusters identified by HCA were limited to identifying which 
symptoms were in each grouping; there was no conceptual basis to suggest symptom 
causation which may indicate suitable clinical intervention {Hair, 2006 #549}. Cluster 
analysis may provide a simplified grouping of symptoms, but if this limits the intended 
application, common factor analysis methods may be more appropriate.   
In HCA, there are no standards, a priori, for most analytical choices, so 
researchers selected arbitrary values to determine groupings that were accepted if they 
were clinically meaningful. The choice of a similarity measure was researcher-selected 
for the context, but was not justified in any study. Conceptually, a symptom cluster 
requires co-occurrence, so when assessing binary data (yes/no), the presence of 
symptom pairs is important. Exclusion of both absent, by using the Jaccard coefficient, 
seems appropriate, but gives a different clinical view on the resulting interpretations, 
and may affect generalizability. Researcher justification of the selected coefficients 
would be helpful for further discussion.   
Many of the analytical decisions by investigators were recommended best-
practice approaches for EFA {Costello, 2005 #789}; common FA methods were 
appropriately used in seven studies, but in three studies PCA was used, although all 
studies had similar clinically-related aims. This difference suggests that not all 
researchers understand that common factor methods are conceptually more appropriate 
than PCA in this symptom clustering context, as common FA methods reflect reality by 
acknowledging that errors occur. In the past, nursing and psychology researchers have 
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often implemented the default software settings for EFA, namely, PCA, eigenvalues > 
1.0, and varimax rotation {Watson, 2006 #544; Fabrigar, 1999 #688}, despite the 
likelihood of obtaining sub-optimal results. This combination of procedures was 
popularized when computing capabilities were limited, but have since been rejected by 
their instigator, Kaiser {Gorsuch, 1990 #823}.  
In deciding on the number of groupings, few methods are available in standard 
software to guide this decision. One researcher used ML to determine the number of 
factors. Otherwise, one or more criteria were used in PAF and PCA, but all investigators 
relied on the clinical relevance of groupings for the final decision. Commonly, 
eigenvalues > 1.0 was one criterion for determining the number of factors, but none of 
the PAF studies determined the final solution from this criterion. The basis for this 
criterion is in PCA and the assessment of total variance, so its application in FA is 
questionable. The scree plot is the preferred guideline for FA methods {Costello, 2005 
#789}, preferably with eigenvalues calculated from the correlation matrix in PAF (with 
communalities). Harman’s rule was used by Cleeland et al. (2000) and in other MDASI 
studies, but the calculation is not available in standard statistical programs. As this 
criterion is based on the difference between the reproduced and observed correlations, a 
simpler option is a visual inspection of the residual correlation matrix {Gorsuch, 1983 
#620}, although using a quantifiable criterion was preferred by several researchers. 
Research supports the extraction of one or two additional factors, rather than under-
extraction {Wood, 1996 #726}, an approach adopted by some researchers. For instance, 
Chen and Tseng (2006) used the eigenvalues > 1.0 criterion to suggest a 2-factor 
solution, but forced a 3-factor solution that they considered was more clinically relevant. 
   
 
 
23  
However, Wang et al. (2006) found the 3-factor solution was not clinically meaningful 
compared to the 2-factor solution. 
To achieve simple structure and an interpretable solution, oblique rotation was 
used most frequently. In this context, using oblique rather than varimax (orthogonal) 
rotation was appropriate, as the unknown symptom groupings may be correlated. In 
instrument development, some correlation between scales is expected, so accurate 
representation and generalizable solutions are more likely to result from oblique rotation 
{Osborne, 2008 #806}. Complete reporting of the pattern, structure, and inter-factor 
correlation matrices would provide additional information for interpretation, but in most 
studies only the pattern matrix was reported, so inter-factor correlations, and 
communalities, could not be calculated. Most researchers support this approach to 
identify groupings from the pattern coefficients {Costello, 2005 #789; Tabachnick, 2007 
#559}, although others suggest groupings should be determined from the structure 
coefficients, as they are more stable across samples {Pett, 2003 #534}. Irrespective of 
approach, the patterning should be consistent in both sets of coefficients. Simple 
structure is not always achieved in the structure matrix due to the correlations between 
factors, and this may explain why interpretations are usually based on the pattern 
coefficients that indicate the unique association of each factor with the variables 
involved. Higher-order factors were not considered in any of the reviewed studies, 
possibly due to low/moderate inter-factor correlations. However, for symptom 
management, primary factors may be of greater interest in identifying symptoms to 
target for intervention, as a higher-order grouping may be too large to be clinically 
useful.     
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The stability of symptom clusters is important for clinical application, despite the 
variation in symptoms that may occur across the disease trajectory. Stability was 
established in three studies by cross-validation {Cleeland, 2000 #308; Mystakidou, 2004 
#473; Wang, 2006 #543}. In several MDASI studies, PAF identified two groupings in 
the initial step to establish construct validity. However, once the 2-cluster structure was 
identified in Cleeland et al.’s study, this hypothesized structure could have been tested 
in successive cross-cultural studies using CFA, but this approach was not adopted. An 
advantage of CFA is that if the model does not fit the data adequately, the model can be 
re-specified and re-tested with a similar sample, thus utilizing CFA in a well 
circumscribed exploratory mode. 
Similar groupings were rarely identified across studies that used different 
assessment tools. In similar studies using the MDASI, whether the two clusters validated 
by Cleeland et al. (2000) and Wang et al. (2006) or the three clusters identified by 
Ivanova et al. (2005) and Chen and Tseng (2006) are the most relevant clinically, 
requires further investigation, ideally using CFA. These differences could be attributed 
to the target population, cultural differences in expression of symptoms, real differences, 
or chance. Several 2-symptom groupings were identified across studies, but in factor 
analysis, the minimal requirement for a stable factor is three {Child, 2006 #755}. If a 2-
symptom grouping is biologically real, it could be expected to be identified consistently, 
and this may be realized as more studies are reported.  
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Limitations 
This review of multivariate methods identifying symptom groupings was limited 
to cross-sectional studies. The majority of studies used PAF rather than ML, PCA, or 
HCA. This imbalance reflects the number of studies associated with the development of 
the MDASI and may reflect researcher awareness that PAF is a conceptually appropriate 
method for symptom cluster identification, particularly when improved symptom 
management is the intended application. Despite the limited number of studies, the 
analytical approaches implemented in these studies represented a variety of commonly-
used options available in standard software.  
 
Further Research 
The number of groupings identifiable from short assessment tools is limited, so 
in this exploratory stage of symptom cluster research, further studies of a representative, 
broad range of symptoms relevant to the target population are required. The symptom 
experience for patients may vary by medical and demographic characteristics, so 
separate analyses for each population subgroup are required, to determine the 
consistency of symptom clusters. However, the ability to conduct sub-group analyses 
depends on an adequate sample size. 
 
Conclusion 
Selecting an optimal analytic method is important to identify symptom groupings 
that are clinically meaningful and stable for cancer populations. Our overview of the 
conceptual and statistical bases of analytical methods indicates there are several 
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limitations of cluster analysis compared to FA, in this context. In cluster analysis, there 
is no set method to identify the most parsimonious set of groupings and the complexity 
of the symptom in relation to other symptoms and some underlying cause may be over-
simplified. Both common FA and HCA are appropriate to group symptoms by co-
occurrence and relatedness, when the structure in the data is unknown. However, FA is 
more appropriate for identifying symptom groupings when the intended application is to 
gain further insight about possible causal paths, for new directions in symptom 
management. Also, FA has the advantage of hypothesizing statistically-testable 
relationships among symptoms and the common factors these relationships may 
indicate. We propose that conceptually, common FA methods are appropriate for 
symptom cluster identification and do not recommend PCA in any context. In addition, 
we do not support the use of eigenvalues greater than 1.0 to suggest the number of 
groupings in FA.  
From this review of studies, we recommend the following approaches for the 
identification of symptom clusters as a basis for symptom management, using standard 
software: (a) common FA methods (e.g. PAF or ML); (b) use of the scree plot to guide 
the number of factors, repeating analyses for an additional factor or two, to determine 
the most clinically-meaningful groupings; and (c) use of oblique rotation. As a 
minimum, the pattern matrix and factor-correlation matrix should be reported, as the 
structure matrix can then be calculated. Cross-validation is necessary to establish the 
stability of groupings for use in clinical assessment and management. CFA was not used 
in the reviewed studies, but would be the optimal approach to validate known groupings 
in a similar sample. 
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Table 1. Symptom Clusters Identified by Common Factor Analysis Methods 
 
Author and 
Purpose 
Study design and 
participants 
Symptom 
measurement 
Analytical decisions Symptom clusters 
(number of symptoms) Extraction 
and  
Rotation 
Number of 
factors 
  
Pattern 
coefficient 
cut-off  
Cleeland et al., 
2000 a 
 
To develop an 
instrument to 
assess symptom 
distress 
N=527 
outpatients, 
various diagnoses 
and treatment 
stages 
Cross-validation: 
N = 113 similar 
outpatients 
 
26 symptom 
checklist 
(reduced to 13 
symptoms by 
HCA) 
Severity in last 
24 hours: 
0 -10 
PAF 
Oblimin 
Harman’s 
rule 
.30 1. General symptoms: pain, fatigue, 
    disturbed sleep, distress, shortness 
    of breath, drowsiness, dry mouth, 
    sadness, memory problems, 
    numbness (10)                                        
 2. Gastrointestinal symptoms: 
     nausea and vomiting (2) 
Okuyama et al., 
2003 a 
 
To translate and 
validate the 
MDASI in 
Japanese 
N=252 patients 
mixed diagnoses, 
randomly 
selected 
MDASI- J 
13 symptoms 
Severity in last 
24 hours: 
0 -10 
PAF 
Oblimin 
Scree plot .30 1. General symptoms: pain, fatigue, 
    disturbed sleep, distress, shortness 
    of breath, drowsiness, dry mouth, 
    sadness, memory problems, 
    numbness, lack of appetite (11)             
 2. Gastrointestinal symptoms: 
     nausea and vomiting (2)            
                                   
Gift et al., 2004 
 
To identify the 
number, type and 
combination of 
symptoms 
experienced by 
lung cancer 
patients 
 
Secondary data  
N=220 elderly 
(≥ 65 years) lung 
cancer patients, 
early and late 
stage, 
mixed therapies 
4-8 weeks after 
diagnosis 
PSE 
32 symptoms 
Severity in 2 
weeks prior: 
0 = absent 
1 = mild 
2 = moderate 
3 = severe 
 
ML ML .40 1. Fatigue, nausea, weakness, 
    appetite loss, weight loss,  
    altered taste, vomiting (7) 
Wang et al., 2004 
 
N=249 advanced 
cancer patients, 
MDASI-C 
13 symptoms 
PAF 
Oblimin 
Scree plot 
E >1.0 
.40 1. General symptoms: pain, fatigue, 
    disturbed sleep, distress, shortness 
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To translate and 
validate the 
MDASI in 
Chinese 
mixed diagnoses 
various 
treatments 
Severity in last 
24 hours: 
0 -10 
Harman’s 
rule 
    of breath, drowsiness, dry mouth, 
    sadness, memory problems, 
    numbness, lack of appetite (11)             
 2. Gastrointestinal symptoms: 
     nausea and vomiting (2)             
                                 
Ivanova et al., 
2005 
 
To translate and 
validate the 
MDASI in 
Russian 
N=226 patients 
Hematological 
malignancies or 
solid tumors 
MDASI-R 
13 symptoms 
Severity in last 
24 hours: 
0 -10 
PAF 
Oblimin 
Scree plot 
E >1.0 
Harman’s 
rule 
.30 1. General Symptom Severity: pain, 
    fatigue, disturbed sleep, 
    drowsiness, lack of appetite (5)             
2. Treatment-related: nausea,  
    vomiting, breathlessness, dry 
    mouth, memory problems, 
    numbness (6)                                        
3. Emotional:  
    distress and sadness (2)                        
Wang, Laudico et 
al., 2006a 
 
To translate and 
validate MDASI 
in Filipino 
 
N=206 cancer 
patients, mixed 
diagnoses and 
treatments 
Cross-validation 
study 
N=170 
community 
adults, no cancer 
MDASI-F 
13 symptoms 
Severity in last 
24 hours: 
0 -10 
PAF 
Oblimin 
Scree plot 
E >1.0 
Harman’s 
rule 
.40 1. General symptoms: pain, fatigue, 
    disturbed sleep, distress, shortness 
    of breath, drowsinessb, dry mouth, 
    sadness, memory problems, 
    numbness, lack of appetiteb (11)            
 2. Gastrointestinal symptoms: 
     nausea and vomiting (2)                       
Chen & Tseng, 
2006 
 
To identify 
symptom clusters 
and validate 
conceptual 
meanings 
N=151 
(128 inpatients) 
Mixed diagnoses, 
various stages of 
disease and 
treatment 
MDASI 
9 symptoms 
(reduced from 
13 symptoms) 
Severity in last 
24 hours: 
0 -10 
PAF 
Oblimin 
E >1.0 
Forced a 3-
factor 
solution, 
based on 
conceptual 
meanings 
.40 1. Sickness – Pain:  
     pain, fatigue, sleep disturbance,  
     lack of appetite, drowsiness (5) 
2. Gastrointestinal – Chemotherapy:    
     nausea and vomiting (2)                       
3. Emotional: distressed and sad (2)          
Note. HCA = hierarchical cluster analysis; PAF = principal axis factoring; ML = maximum likelihood factoring; E = eigenvalues; MDASI = M.D. Anderson 
Symptom Inventory; MDASI-J = M.D. Anderson Symptom Inventory, Japanese; MDASI-C = M.D. Anderson Symptom Inventory, Chinese; MDASI-R = M.D. 
Anderson Symptom Inventory, Russian; MDASI-F = M.D. Anderson Symptom Inventory, Filipino; PSE = Physical Symptom Experience {Given, 1993 #521}. 
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aGroupings also identified by HCA. bLoadings below .30. 
 
Table 2. Symptom Clusters Identified by Principal Components Analysis  
 
Author and 
Purpose 
Study design and 
participants 
Symptom 
measurement 
Decisions for analysis Symptom clusters 
(number of symptoms) Rotation 
 
Number of 
components 
  
 
Pattern 
coefficient 
cut-off for 
symptom 
inclusion 
 
Sarna & Brecht, 
1997 
 
To explore the 
underlying 
dimensions and 
structure of 
symptom 
distress 
Secondary data 
analysis 
N=60 women  
advanced  lung 
cancer following 
chemotherapy 
and/or radiation 
SDS 
13 symptoms 
In past week: 
1 = no 
distress 
5 = very 
distressed 
Varimax 
 
E > 1.0 .40 1. Emotional and Physical Suffering: 
    pain frequency & severity, 
    bowel, appearance, outlook (5) 
2. Gastrointestinal Distress:  
     nausea frequency & severity, 
     appetite  (3) 
3. Respiratory Distress: insomnia, 
    breathing, cough  (3) 
4. Malaise: fatigue, concentration (2) 
 
Mystakidou et 
al., 2004 
 
To translate and 
validate 
MDASI in 
Greek 
N=150  
mixed cancer 
outpatients, 
palliative care, 
treatment for pain 
relief 
Cross-validation 
study  in similar 
outpatient sample 
MDASI- G 
14 symptoms 
(reduced from 
17 symptoms 
by HCA)  
Severity in 
last 24 hours: 
0 -10 
Varimax E > 1.0 
Scree plot 
 
.30 (includes interference items) 
 
1. Enjoyment of life, walking, 
    relationship with people, general 
    activity, sadness, pain (6)      
                                         
2. Dry mouth, numbness or tingling, 
    loss of memory, nausea,   
    constipation, emesis (6)  
                                             
3. Distress, shortness of breath, sleep 
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    disturbance, loss of appetite, 
    fatigue, sleepiness (6) 
Armstrong et 
al., 2006 
 
To test 
reliability and 
validity of 
MDASI-BT 
scale 
N=210  
primary brain 
tumor patients 
 
31 symptom 
checklist 
(reduced to 22 
symptoms by 
HCA) 
Severity in 
last 24 hours: 
0 -10 
Varimax 
 
Harman’s 
rule 
 
.40 1. Affective: distress, fatigue, sleep,  
    sad, irritability  (5)  
 
2. Cognitive:  
    difficulty understanding, 
    speaking and concentrating (3) 
3. Focal neurologic deficit:  
    seizures, numbness, pain,  
    weakness (4) 
4. Treatment-related: dry mouth, 
    drowsiness, appetite (3)                    
5. Generalized/disease status: 
    change in appearance, vision,  
    bowel patterns, shortness of 
   breath (4)                                         
6.  GI-related: nausea, vomiting (2) 
Note. HCA = hierarchical cluster analysis; E = eigenvalues; SDS = Symptom Distress Scale {McCorkle, 1978 #322}; MDASI-G = M.D. 
Anderson Symptom Inventory, Greek; MDASI-BT = M.D. Anderson Symptom Inventory, Brain Tumor module. 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
31  
 
 
 
 
Table 3. Symptom Clusters Identified by Hierarchical Cluster Analysis  
 
Author and 
Purpose 
Study design and 
participants 
Symptom 
measurement 
Decisions for analysis Symptom clusters 
(number of symptoms) Similarity 
measures 
Method 
of 
linkage 
Cut-point 
for 
symptom 
inclusion 
Bender et 
al., 2005 
 
To describe 
symptom 
clusters 
across 3 
phases of 
breast 
cancer 
 
Secondary data 
analysis, pooled 
data 
N=154 
breast cancer 
patients 
Study 1: n=40 
early stage, no 
treatment 
Study 2: n=88 
Stage 1, 2, 3  
complete treatment 
Study 3: n=26 
Stage 4, metasteses, 
palliative care 
Presence of 
13 symptoms 
common across 
3 studies 
(decided by 
expert panel) 
 
 
4-point phi 
correlation 
coefficients 
  Common clusters across studies: 
1. Fatigue:  lack of energy,   
    decreased physical strength 
     /weakness (2)  
2. Perceived cognitive impairment: 
    memory, loss of concentration (2) 
3. Mood problems: 
    anxiety and depression (2) 
 
 
Glaus et al., 
2006 
 
To identify 
symptom 
clusters 
N= 373 breast 
cancer patients 
following hormonal 
therapy 
Early: N=301 
Advanced: N=72 
C-PET 
Presence  
8 symptoms 
 
IBCSG/LASA 
Intensity (mm) 
1-Jaccard 
coefficient 
 
 
1-squared 
correlation 
Average 
linkage 
 
 
Average 
linkage 
> 15% 
prevalence 
Cut-point: 
.8 
 
  1.  Hot flashes, weight gain, 
       tiredness, decreased sexual 
       interest, vaginal dryness (5) 
 
 3 clusters based on LASA ratings  
       
   
 
 
32  
coefficient 
Walsh & 
Rybicki, 
2006 
 
To identify 
the presence 
and 
composition 
of symptom 
clusters 
 
Secondary data 
analysis 
N=922  
advanced cancer 
patients 
mixed diagnoses 
No anti-tumor 
treatment 
palliative care 
25 of 38 
symptoms 
Severity ratings: 
mild 
 moderate 
 severe 
 
 
 
Correlation 
coefficient 
Average 
linkage 
> 15% 
prevalence 
Cut-point: 
absolute 
value of 
correlation 
> .68 
between 
symptoms 
1. Fatigue: anorexia-cachexia;   
    Easy fatigue, weakness,  
    anorexia, lack of energy, dry 
    mouth, early satiety, weight 
   loss, taste changes (8) 
2. Neuropsychological: sleep 
    problems, depression, anxiety (3) 
3. Upper GI:  dizzy spells,  
     dyspepsia, belching, bloating (4) 
4.  Nausea and vomiting (2) 
5. Aerodigestive: dysphagia, 
   dyspnea, cough, hoarseness (4) 
6. Debility: edema, confusion (2) 
7. Pain: pain, constipation (2) 
Note. C-PET = Checklist for Patients with Endocrine Therapy {Hopwood, 1998 #807}; IBCSG/LASA = International Breast Cancer Study Group/linear analogue scales 
{Bernhard, 1997 #808} 
 
 
 
 
 
 
 
 
 
 
